A GI-MAP H. pylori result reports laboratory findings that need clinical interpretation. It does not, by itself, explain every digestive symptom, diagnose an ulcer or determine whether you have cancer.
Start with the full report, rather than a screenshot of one flagged number. Check the assay name, collection date, laboratory comments and why testing was requested. Then review the findings with a clinician who can connect them to your symptoms, history and any previous treatment.
What does the H. pylori section measure?
GI-MAP uses quantitative PCR for its H. pylori component. PCR detects targeted DNA; “quantitative” means the assay reports an amount according to its measurement system. The report also includes selected genetic targets associated with virulence and antibiotic resistance. These are manufacturer-described specifications, not proof that the test is more accurate than every alternative. DSL methodology guide
| Part of the report | What to ask about | What it cannot establish by itself |
|---|---|---|
| H. pylori quantity or flag | What does this value mean under this laboratory's interpretation rules? | How severe your symptoms should be or whether you have an ulcer |
| Virulence markers | Which targets were assessed and how would this affect management? | Your personal probability of developing cancer |
| Resistance-associated markers | Which antibiotic targets and variants were covered? | A complete antibiotic prescription or guaranteed treatment success |
| A negative finding | Was timing and preparation appropriate, and is further assessment needed? | That every cause of your symptoms has been excluded |
For orientation, see the sample report. Reference ranges and detection limits belong to the named assay and report version; do not compare a number directly with another laboratory's scale.
Does a higher number mean a more dangerous infection?
Do not use the number as a personal severity score. The clinical question is whether the finding represents infection that needs management in your circumstances, and whether symptoms need additional investigation. A flagged result should lead to a clinical discussion, not a self-selected treatment based on how far the number sits above a reference line.
The distinction matters when comparing results over time. Before interpreting a change, ask whether the same method was used, whether collection conditions differed and whether the follow-up test was suitable for the purpose. A smaller number is not automatically proof of eradication.
For resistance flags, see the focused H. pylori antibiotic-resistance marker guide.
What are virulence genes?
Virulence concerns characteristics that can contribute to an organism's ability to cause disease. The manufacturer's interpretive guide reviewed on October 6, 2026 lists eight H. pylori targets: babA, cagA, dupA, iceA, oipA, vacA, virB, virD. DSL interpretive guide, H. pylori section
Confirm which targets appear on your current report with the laboratory; panels and report formats can change. The names describe laboratory targets. A detected target is not a diagnosis of stomach damage, and an undetected target is not a promise that infection is harmless. Do not translate “virulence factor present” into “I will get cancer,” or “virulence factors absent” into “I do not need medical advice.” The relationship between H. pylori and cancer involves infection, host factors and the condition of the stomach over time. NCI
Can resistance markers tell me which medicine to take?
Selected molecular tests can identify genetic changes associated with resistance. That information may help a prescriber, but the meaning depends on the assay and variants tested. It is not the same as testing the organism against every available antibiotic. Current US treatment guidance also takes prior treatment and susceptibility information into account. Mayo Clinic Laboratories pathway, ACG 2024
Ask the prescriber whether the reported finding is sufficiently validated and relevant to the proposed regimen. An absent resistance marker does not guarantee that a particular antibiotic will work. Allergies, interactions and previous antibiotic use still matter.
What if GI-MAP is positive and another test is negative?
A quantity or virulence flag is not a tie-breaker between methods. Bring both complete reports to your clinician and use our negative and conflicting results guide to organise the test names, dates and preparation history. The independent GI-MAP study raises assay-specific concerns but cannot determine which result is correct for you.
What if the report is negative?
A negative test reduces concern only to the extent that the method, preparation and clinical context support that interpretation. It does not explain ongoing symptoms or replace evaluation when warning signs are present. Your clinician may assess other causes or reconsider testing conditions. MedlinePlus
Seek urgent care for bleeding symptoms or severe persistent abdominal pain. Do not wait for a second mail-in panel to decide whether to get help. Mayo Clinic
Five questions for your result appointment
- Does this finding establish infection in my clinical circumstances, or is clarification needed?
- Could preparation or recent treatment affect the result?
- Which reported markers would actually change my care?
- Who will prescribe and monitor treatment if it is needed?
- Which test and timing will confirm eradication afterward?
For the next stage after confirmed infection, our treatment and retesting guide explains the plan to agree with a prescriber.
Next step: take your full report to the clinician managing your care. If you are considering a first test, the central H. pylori guide explains the clinical starting points.
Sources: DSL methodology and interpretive guides, identified as manufacturer material; NCI; Mayo Clinic Laboratories; ACG 2024; Gingras and Maggiore 2020; MedlinePlus; Mayo Clinic. See inline citations.
For a correction or source question, contact Gi Map Test.